“Even though we have URAC and ACHC accreditation, we decided to pursue NCODA’s accreditation because we felt it would benefit our practice,” said Meg Butler, PharmD, with Clearview Cancer Center. The CoE MIP Accreditation eliminates clinical fragmentation and administrative burdens and provides innovative standards and tools specifically designed to improve outcomes and enhance the quality of services. This three-year accreditation, based on compliance with the ASCO/NCODA Patient-Centered Standards for Medically Integrated Dispensing is the only accreditation program designed specifically for medically integrated practices. We look forward to having more involvement in the NCODA community.” Prior to this process, we had already adopted patient-centered practices however, we are constantly striving for enhancements and this accreditation allows us just that. At Rx To Go, we do a tremendous job supporting our patients and our team. “The emphasis on medical integration, and its importance in the oncology care model, has been very constructive for everyone involved. “Participating in the NCODA MIP Accreditation has been a valuable opportunity for our team and patients,” said Kara Sammons, Director of Quality and Compliance – Pharmacy for Rx To Go. The newly accredited practices include Clearview Cancer Institute, Rx To Go, LLC at Florida Cancer Specialists & Research Institute, and Southern Oncology and Hematology Associates. – Three leading medically integrated oncology practices were awarded NCODA’s Center of Excellence Medically Integrated Pharmacy Accreditation at the NCODA International Spring Forum that took place on March 15 – 17, 2023 in Indianapolis, IN.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |